These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Discovery of GuaB inhibitors with efficacy against Acinetobacter baumannii infection. Kofoed EM, Aliagas I, Crawford T, Mao J, Harris SF, Xu M, Wang S, Wu P, Ma F, Clark K, Sims J, Xu Y, Peng Y, Skippington E, Yang Y, Reeder J, Ubhayakar S, Baumgardner M, Yan Z, Chen J, Park S, Zhang H, Yen C-W, Lorenzo M, Skelton N, Liang X, Chen L, Hoag B, Li CS, Liu Z, Wai J, Liu X, Liang J, Tan MW. mBio; 2024 Oct 16; 15(10):e0089724. PubMed ID: 39207111 [Abstract] [Full Text] [Related]
6. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity. Kim S, Jin JS, Choi YJ, Kim J. Viruses; 2020 Nov 23; 12(11):. PubMed ID: 33238548 [Abstract] [Full Text] [Related]
11. Characterization of a Novel Phage ΦAb1656-2 and Its Endolysin with Higher Antimicrobial Activity against Multidrug-Resistant Acinetobacter baumannii. Kim K, Islam MM, Kim D, Yun SH, Kim J, Lee JC, Shin M. Viruses; 2021 Sep 16; 13(9):. PubMed ID: 34578429 [Abstract] [Full Text] [Related]
12. Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1). Huang G, Shen X, Gong Y, Dong Z, Zhao X, Shen W, Wang J, Hu F, Peng Y. BMC Infect Dis; 2014 Dec 12; 14():681. PubMed ID: 25495514 [Abstract] [Full Text] [Related]
13. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria. Zhang S, Chang Y, Zhang Q, Yuan Y, Qi Q, Lu X. Microb Cell Fact; 2022 Aug 23; 21(1):171. PubMed ID: 35999567 [Abstract] [Full Text] [Related]
14. Antimicrobial peptide thanatin fused endolysin PA90 (Tha-PA90) for the control of Acinetobacter baumannii infection in mouse model. Lim J, Myung H, Lim D, Song M. J Biomed Sci; 2024 Apr 15; 31(1):36. PubMed ID: 38622637 [Abstract] [Full Text] [Related]
16. Anti-multidrug-resistant Acinetobacter baumannii activity of DS-8587: In vitro activity and in vivo efficacy in a murine calf muscle infection model. Higuchi S, Kurosaka Y, Uoyama S, Yoshida K, Chiba M, Ishii C, Fujikawa K, Karibe Y, Hoshino K. J Infect Chemother; 2014 May 15; 20(5):312-6. PubMed ID: 24594453 [Abstract] [Full Text] [Related]
17. LysJEP8: A promising novel endolysin for combating multidrug-resistant Gram-negative bacteria. Carratalá JV, Ferrer-Miralles N, Garcia-Fruitós E, Arís A. Microb Biotechnol; 2024 Jun 15; 17(6):e14483. PubMed ID: 38864495 [Abstract] [Full Text] [Related]
18. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens. Dillon N, Holland M, Tsunemoto H, Hancock B, Cornax I, Pogliano J, Sakoulas G, Nizet V. EBioMedicine; 2019 Aug 15; 46():193-201. PubMed ID: 31353294 [Abstract] [Full Text] [Related]